nodes	percent_of_prediction	percent_of_DWPC	metapath
Metocurine—CHRNA1—Galantamine—Alzheimer's disease	0.236	0.267	CbGbCtD
Metocurine—CHRND—Galantamine—Alzheimer's disease	0.236	0.267	CbGbCtD
Metocurine—CHRNB1—Galantamine—Alzheimer's disease	0.236	0.267	CbGbCtD
Metocurine—CHRNA2—Galantamine—Alzheimer's disease	0.174	0.197	CbGbCtD
Metocurine—Tubocurarine—ACHE—Alzheimer's disease	0.00457	1	CrCbGaD
Metocurine—CHRND—Transmission across Chemical Synapses—ACHE—Alzheimer's disease	0.000265	0.0024	CbGpPWpGaD
Metocurine—CHRND—Transmission across Chemical Synapses—CHRNA4—Alzheimer's disease	0.000262	0.00237	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—GRIK2—Alzheimer's disease	0.000262	0.00237	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—GRIK1—Alzheimer's disease	0.000262	0.00237	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—CHAT—Alzheimer's disease	0.000262	0.00237	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—CHRNA7—Alzheimer's disease	0.000262	0.00237	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—GRIA1—Alzheimer's disease	0.000259	0.00235	CbGpPWpGaD
Metocurine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Alzheimer's disease	0.000255	0.00231	CbGpPWpGaD
Metocurine—CHRNA2—forebrain—Alzheimer's disease	0.000253	0.157	CbGeAlD
Metocurine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Alzheimer's disease	0.000249	0.00226	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—CHRNA7—Alzheimer's disease	0.000249	0.00225	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—GRIK1—Alzheimer's disease	0.000249	0.00225	CbGpPWpGaD
Metocurine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB1—Alzheimer's disease	0.000246	0.00223	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—GRIA1—Alzheimer's disease	0.000246	0.00223	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—CHRNB2—Alzheimer's disease	0.000245	0.00222	CbGpPWpGaD
Metocurine—CHRNA1—ErbB2/ErbB3 signaling events—MAPK8—Alzheimer's disease	0.000245	0.00222	CbGpPWpGaD
Metocurine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Alzheimer's disease	0.000242	0.00219	CbGpPWpGaD
Metocurine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Alzheimer's disease	0.000237	0.00214	CbGpPWpGaD
Metocurine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB1—Alzheimer's disease	0.000234	0.00212	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—GRIA1—Alzheimer's disease	0.000233	0.00211	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—CHRNB2—Alzheimer's disease	0.000233	0.00211	CbGpPWpGaD
Metocurine—CHRND—Transmission across Chemical Synapses—BCHE—Alzheimer's disease	0.000231	0.00209	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—ACHE—Alzheimer's disease	0.000225	0.00204	CbGpPWpGaD
Metocurine—CHRND—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	0.000225	0.00204	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—CHRNA4—Alzheimer's disease	0.000223	0.00202	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—CHAT—Alzheimer's disease	0.000223	0.00202	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—GRIK2—Alzheimer's disease	0.000223	0.00202	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—CHRNB2—Alzheimer's disease	0.000221	0.002	CbGpPWpGaD
Metocurine—CHRND—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	0.00022	0.00199	CbGpPWpGaD
Metocurine—CHRND—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	0.000218	0.00197	CbGpPWpGaD
Metocurine—CHRM2—Monoamine GPCRs—HTR2A—Alzheimer's disease	0.000214	0.00194	CbGpPWpGaD
Metocurine—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—Alzheimer's disease	0.000214	0.00194	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—ACHE—Alzheimer's disease	0.000214	0.00194	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—CHRNA4—Alzheimer's disease	0.000212	0.00192	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—CHAT—Alzheimer's disease	0.000212	0.00192	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—GRIK2—Alzheimer's disease	0.000212	0.00192	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—ACHE—Alzheimer's disease	0.000203	0.00184	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—CHRNA4—Alzheimer's disease	0.000201	0.00182	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—GRIA1—Alzheimer's disease	0.000198	0.0018	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—BCHE—Alzheimer's disease	0.000196	0.00178	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—MAP2—Alzheimer's disease	0.000196	0.00177	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	0.000192	0.00173	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—GRIA1—Alzheimer's disease	0.000189	0.00171	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—CHRNB2—Alzheimer's disease	0.000188	0.0017	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	0.000187	0.0017	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—BCHE—Alzheimer's disease	0.000186	0.00169	CbGpPWpGaD
Metocurine—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—Alzheimer's disease	0.000185	0.00168	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	0.000185	0.00168	CbGpPWpGaD
Metocurine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—Alzheimer's disease	0.000182	0.00165	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	0.000182	0.00165	CbGpPWpGaD
Metocurine—CHRM2—Amine ligand-binding receptors—HTR2A—Alzheimer's disease	0.00018	0.00163	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—CHRNB2—Alzheimer's disease	0.000179	0.00162	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	0.000178	0.00161	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—BCHE—Alzheimer's disease	0.000177	0.0016	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	0.000176	0.00159	CbGpPWpGaD
Metocurine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—Alzheimer's disease	0.000173	0.00157	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—ACHE—Alzheimer's disease	0.000173	0.00156	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—DLG4—Alzheimer's disease	0.000173	0.00156	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—CHRNA4—Alzheimer's disease	0.000171	0.00155	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—GRIN2B—Alzheimer's disease	0.000169	0.00153	CbGpPWpGaD
Metocurine—CHRM2—Calcium Regulation in the Cardiac Cell—YWHAQ—Alzheimer's disease	0.000167	0.00151	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—PLCB1—Alzheimer's disease	0.000167	0.00151	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—TP73—Alzheimer's disease	0.000166	0.00151	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—CHRNA7—Alzheimer's disease	0.000166	0.00151	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—ACHE—Alzheimer's disease	0.000164	0.00149	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—CHRNA4—Alzheimer's disease	0.000162	0.00147	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—YWHAQ—Alzheimer's disease	0.000161	0.00146	CbGpPWpGaD
Metocurine—CHRND—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	0.000161	0.00146	CbGpPWpGaD
Metocurine—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—Alzheimer's disease	0.000159	0.00144	CbGpPWpGaD
Metocurine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—Alzheimer's disease	0.000158	0.00143	CbGpPWpGaD
Metocurine—CHRM2—forebrain—Alzheimer's disease	0.000151	0.0935	CbGeAlD
Metocurine—CHRNA1—Neuronal System—BCHE—Alzheimer's disease	0.00015	0.00136	CbGpPWpGaD
Metocurine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—Alzheimer's disease	0.00015	0.00136	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—PYY—Alzheimer's disease	0.000149	0.00135	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—DLG4—Alzheimer's disease	0.000147	0.00133	CbGpPWpGaD
Metocurine—CHRNA1—ErbB2/ErbB3 signaling events—AKT1—Alzheimer's disease	0.000144	0.00131	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—GRIN2B—Alzheimer's disease	0.000143	0.0013	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—BCHE—Alzheimer's disease	0.000143	0.00129	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—PLCB1—Alzheimer's disease	0.000142	0.00128	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	0.000142	0.00128	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—DLG4—Alzheimer's disease	0.000139	0.00126	CbGpPWpGaD
Metocurine—CHRND—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	0.000139	0.00126	CbGpPWpGaD
Metocurine—CHRM2—telencephalon—Alzheimer's disease	0.000139	0.0859	CbGeAlD
Metocurine—CHRNA2—nervous system—Alzheimer's disease	0.000137	0.0851	CbGeAlD
Metocurine—CHRNA1—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	0.000137	0.00124	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—GRIN2B—Alzheimer's disease	0.000136	0.00123	CbGpPWpGaD
Metocurine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—Alzheimer's disease	0.000135	0.00122	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—PLCB1—Alzheimer's disease	0.000135	0.00122	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	0.000133	0.0012	CbGpPWpGaD
Metocurine—CHRNA2—central nervous system—Alzheimer's disease	0.000132	0.0819	CbGeAlD
Metocurine—CHRM2—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	0.000131	0.00118	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	0.00013	0.00118	CbGpPWpGaD
Metocurine—CHRNA2—cerebellum—Alzheimer's disease	0.000129	0.0801	CbGeAlD
Metocurine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—Alzheimer's disease	0.000128	0.00116	CbGpPWpGaD
Metocurine—CHRNA1—brain—Alzheimer's disease	0.000127	0.0784	CbGeAlD
Metocurine—CHRND—Neuronal System—PRKCG—Alzheimer's disease	0.000123	0.00112	CbGpPWpGaD
Metocurine—CHRNB1—cerebellum—Alzheimer's disease	0.00012	0.0745	CbGeAlD
Metocurine—CHRM2—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	0.000119	0.00108	CbGpPWpGaD
Metocurine—CHRND—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	0.000119	0.00108	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	0.000119	0.00107	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—PYY—Alzheimer's disease	0.000118	0.00107	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR6—Alzheimer's disease	0.000115	0.00104	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	0.000113	0.00102	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	0.000108	0.000982	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—TF—Alzheimer's disease	0.000107	0.000971	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—CALM1—Alzheimer's disease	0.000107	0.000967	CbGpPWpGaD
Metocurine—CHRNA2—brain—Alzheimer's disease	0.000105	0.065	CbGeAlD
Metocurine—CHRNA1—Neuronal System—PRKCG—Alzheimer's disease	0.000105	0.00095	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—GAL—Alzheimer's disease	0.000103	0.000934	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	0.000101	0.000919	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	0.000101	0.000913	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—PRKCG—Alzheimer's disease	9.97e-05	0.000903	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR6—Alzheimer's disease	9.87e-05	0.000894	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—SST—Alzheimer's disease	9.81e-05	0.000888	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	9.81e-05	0.000888	CbGpPWpGaD
Metocurine—CHRNB1—brain—Alzheimer's disease	9.77e-05	0.0605	CbGeAlD
Metocurine—CHRM2—GPCRs, Other—CCR5—Alzheimer's disease	9.73e-05	0.000881	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	9.64e-05	0.000873	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Other—HTR2A—Alzheimer's disease	9.52e-05	0.000862	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—CREB1—Alzheimer's disease	9.14e-05	0.000828	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—CALM1—Alzheimer's disease	9.08e-05	0.000822	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—PYY—Alzheimer's disease	9.01e-05	0.000816	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—CALM1—Alzheimer's disease	8.63e-05	0.000781	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—GAL—Alzheimer's disease	8.2e-05	0.000742	CbGpPWpGaD
Metocurine—CHRM2—nervous system—Alzheimer's disease	8.19e-05	0.0507	CbGeAlD
Metocurine—CHRM2—G alpha (i) signalling events—NPY—Alzheimer's disease	8.1e-05	0.000733	CbGpPWpGaD
Metocurine—CHRM2—central nervous system—Alzheimer's disease	7.89e-05	0.0488	CbGeAlD
Metocurine—CHRNA1—Neuronal System—CREB1—Alzheimer's disease	7.77e-05	0.000704	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	7.54e-05	0.000682	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—HTR6—Alzheimer's disease	7.52e-05	0.000681	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—CREB1—Alzheimer's disease	7.38e-05	0.000669	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	7.32e-05	0.000663	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—SST—Alzheimer's disease	7.07e-05	0.00064	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	7.03e-05	0.000637	CbGpPWpGaD
Metocurine—CHRM2—Calcium Regulation in the Cardiac Cell—PRKCG—Alzheimer's disease	6.92e-05	0.000627	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—APP—Alzheimer's disease	6.89e-05	0.000624	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	6.8e-05	0.000616	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	6.5e-05	0.000588	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	6.44e-05	0.000583	CbGpPWpGaD
Metocurine—CHRM2—brain—Alzheimer's disease	6.26e-05	0.0388	CbGeAlD
Metocurine—CHRM2—GPCR ligand binding—GAL—Alzheimer's disease	6.24e-05	0.000565	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	6.19e-05	0.00056	CbGpPWpGaD
Metocurine—CHRM2—Calcium Regulation in the Cardiac Cell—CALM1—Alzheimer's disease	5.99e-05	0.000542	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	5.89e-05	0.000533	CbGpPWpGaD
Metocurine—CHRM2—Regulation of Actin Cytoskeleton—F2—Alzheimer's disease	5.63e-05	0.000509	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	5.62e-05	0.000509	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	5.48e-05	0.000496	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—PYY—Alzheimer's disease	5.09e-05	0.000461	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	4.94e-05	0.000447	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—NPY—Alzheimer's disease	4.9e-05	0.000444	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—IAPP—Alzheimer's disease	4.87e-05	0.000441	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—CRH—Alzheimer's disease	4.73e-05	0.000428	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—PYY—Alzheimer's disease	4.62e-05	0.000419	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—CCR5—Alzheimer's disease	4.55e-05	0.000412	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—NPS—Alzheimer's disease	4.49e-05	0.000406	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—SST—Alzheimer's disease	4.28e-05	0.000387	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—HTR6—Alzheimer's disease	4.25e-05	0.000385	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	4.23e-05	0.000383	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—APP—Alzheimer's disease	4.17e-05	0.000378	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	4.14e-05	0.000375	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—CDK5—Alzheimer's disease	4.01e-05	0.000363	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—HTR6—Alzheimer's disease	3.86e-05	0.000349	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	3.67e-05	0.000332	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	3.66e-05	0.000331	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	3.62e-05	0.000328	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	3.54e-05	0.000321	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—GAL—Alzheimer's disease	3.53e-05	0.000319	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—GAL—Alzheimer's disease	3.2e-05	0.00029	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—TTR—Alzheimer's disease	3.12e-05	0.000283	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	3.11e-05	0.000281	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	3.1e-05	0.000281	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—NPY—Alzheimer's disease	2.77e-05	0.000251	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	2.77e-05	0.000251	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—CCR5—Alzheimer's disease	2.76e-05	0.00025	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—IAPP—Alzheimer's disease	2.75e-05	0.000249	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—PYY—Alzheimer's disease	2.73e-05	0.000247	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—HTR2A—Alzheimer's disease	2.7e-05	0.000244	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—CRH—Alzheimer's disease	2.67e-05	0.000242	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	2.66e-05	0.000241	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—NPS—Alzheimer's disease	2.54e-05	0.00023	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—NPY—Alzheimer's disease	2.52e-05	0.000228	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—IAPP—Alzheimer's disease	2.5e-05	0.000226	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—CRH—Alzheimer's disease	2.43e-05	0.00022	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—GAB2—Alzheimer's disease	2.42e-05	0.000219	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—SST—Alzheimer's disease	2.42e-05	0.000219	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CDK5—Alzheimer's disease	2.37e-05	0.000214	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—F2—Alzheimer's disease	2.37e-05	0.000214	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—APP—Alzheimer's disease	2.36e-05	0.000213	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—NPS—Alzheimer's disease	2.3e-05	0.000208	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—PPP3CA—Alzheimer's disease	2.29e-05	0.000207	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—HTR6—Alzheimer's disease	2.28e-05	0.000206	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—PLCB1—Alzheimer's disease	2.22e-05	0.000201	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—SST—Alzheimer's disease	2.2e-05	0.000199	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—GAB2—Alzheimer's disease	2.2e-05	0.000199	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	2.15e-05	0.000194	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—APP—Alzheimer's disease	2.14e-05	0.000194	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—CCL2—Alzheimer's disease	2.11e-05	0.000191	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—PSENEN—Alzheimer's disease	2.07e-05	0.000187	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—APH1A—Alzheimer's disease	2.04e-05	0.000185	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—PLCB1—Alzheimer's disease	2.02e-05	0.000183	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—NCSTN—Alzheimer's disease	1.99e-05	0.00018	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—LRP1—Alzheimer's disease	1.94e-05	0.000175	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—GAL—Alzheimer's disease	1.89e-05	0.000171	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—GFAP—Alzheimer's disease	1.89e-05	0.000171	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—A2M—Alzheimer's disease	1.67e-05	0.000151	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.64e-05	0.000149	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—PSEN2—Alzheimer's disease	1.62e-05	0.000146	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—CCR5—Alzheimer's disease	1.56e-05	0.000141	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.53e-05	0.000138	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—PRKCG—Alzheimer's disease	1.49e-05	0.000135	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—NPY—Alzheimer's disease	1.49e-05	0.000135	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—IAPP—Alzheimer's disease	1.48e-05	0.000134	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CRH—Alzheimer's disease	1.43e-05	0.00013	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—CCR5—Alzheimer's disease	1.42e-05	0.000128	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—HTR2A—Alzheimer's disease	1.38e-05	0.000125	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—NPS—Alzheimer's disease	1.36e-05	0.000123	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—PPP3CA—Alzheimer's disease	1.35e-05	0.000123	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—F2—Alzheimer's disease	1.34e-05	0.000121	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—PTK2B—Alzheimer's disease	1.33e-05	0.000121	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—GAB2—Alzheimer's disease	1.3e-05	0.000117	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—NTRK2—Alzheimer's disease	1.3e-05	0.000117	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—SST—Alzheimer's disease	1.3e-05	0.000117	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—CALM1—Alzheimer's disease	1.29e-05	0.000117	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—GSK3A—Alzheimer's disease	1.29e-05	0.000116	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—APP—Alzheimer's disease	1.26e-05	0.000114	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—F2—Alzheimer's disease	1.21e-05	0.00011	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—PLCB1—Alzheimer's disease	1.19e-05	0.000108	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—NGFR—Alzheimer's disease	1.11e-05	0.000101	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—CREB1—Alzheimer's disease	1.11e-05	0.0001	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—ADAM10—Alzheimer's disease	1.09e-05	9.84e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—CCL2—Alzheimer's disease	1.08e-05	9.8e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—S100B—Alzheimer's disease	1.03e-05	9.31e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—IGF2—Alzheimer's disease	9.79e-06	8.86e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—IGF1R—Alzheimer's disease	9.46e-06	8.57e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—LPL—Alzheimer's disease	9.07e-06	8.22e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—MEF2C—Alzheimer's disease	8.99e-06	8.14e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—PRKCG—Alzheimer's disease	8.82e-06	7.99e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—NGF—Alzheimer's disease	8.59e-06	7.78e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CCR5—Alzheimer's disease	8.36e-06	7.57e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—HTR2A—Alzheimer's disease	8.18e-06	7.41e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CALM1—Alzheimer's disease	7.63e-06	6.91e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—LEP—Alzheimer's disease	7.61e-06	6.89e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—APOE—Alzheimer's disease	7.61e-06	6.89e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CAV1—Alzheimer's disease	7.54e-06	6.82e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—ESR1—Alzheimer's disease	7.26e-06	6.57e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—F2—Alzheimer's disease	7.17e-06	6.49e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—NOTCH1—Alzheimer's disease	7.02e-06	6.36e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	6.59e-06	5.96e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	6.53e-06	5.92e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—INS—Alzheimer's disease	6.5e-06	5.88e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	6.39e-06	5.79e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	6.28e-06	5.69e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	5.7e-06	5.16e-05	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	4.88e-06	4.42e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	4.84e-06	4.38e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	4.81e-06	4.35e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	4.45e-06	4.03e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	4.43e-06	4.01e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	4.11e-06	3.72e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	3.77e-06	3.41e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	3.1e-06	2.81e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	2.84e-06	2.57e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	2.62e-06	2.37e-05	CbGpPWpGaD
